The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis

James M Grichnik, James A. Burch, James Burchette, Christopher R. Shea

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

During development, the interaction of stem cell factor (SCF) with its receptor, KIT, is critical for the survival of melanocytes. Limited in vivo human studies have suggested a possible activating role of SCF on adult human melanocytes. In order to study the impact of this pathway on normal melanocyte homeostasis, human skin xenografts were treated with serial injections of recombinant human SCF or a KIT-inhibitory antibody (K44.2). On histologic evaluation, SCF injection increase d, whereas KIT inhibition decreased the number, size, and dendricity of melanocytes. Immunohistochemical expression of melanocyte differentiation antigens, including tyrosinase-related- protein-1 and gp100/pmel17, was markedly increased by treatment with SCF, and decreased by K44.2 treatment. The number of Ki67-positive melanocytes was increased in the SCF-treated tissue, suggesting a direct proliferative effect of SCF; conversely, treatment with K44.2 resulted in melanocyte loss, which did not appear reversible with prolonged treatment. These findings demonstrate that the SCF/KIT pathway remains critical in adult human skin, and that pharmacologic modulation of this single pathway can control cutaneous melanocyte homeostasis.

Original languageEnglish
Pages (from-to)233-238
Number of pages6
JournalJournal of Investigative Dermatology
Volume111
Issue number2
DOIs
StatePublished - Aug 11 1998
Externally publishedYes

Fingerprint

Stem Cell Factor
Melanocytes
Homeostasis
Skin
Injections
Critical Pathways
Differentiation Antigens
Therapeutics
Heterografts
Modulation
Tissue
Antibodies

Keywords

  • HMB-45
  • K44.2
  • Mast cell growth factor
  • Xenograft

ASJC Scopus subject areas

  • Dermatology

Cite this

The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. / Grichnik, James M; Burch, James A.; Burchette, James; Shea, Christopher R.

In: Journal of Investigative Dermatology, Vol. 111, No. 2, 11.08.1998, p. 233-238.

Research output: Contribution to journalArticle

Grichnik, James M ; Burch, James A. ; Burchette, James ; Shea, Christopher R. / The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. In: Journal of Investigative Dermatology. 1998 ; Vol. 111, No. 2. pp. 233-238.
@article{6cc0c335d4324268a66ba418a4083587,
title = "The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis",
abstract = "During development, the interaction of stem cell factor (SCF) with its receptor, KIT, is critical for the survival of melanocytes. Limited in vivo human studies have suggested a possible activating role of SCF on adult human melanocytes. In order to study the impact of this pathway on normal melanocyte homeostasis, human skin xenografts were treated with serial injections of recombinant human SCF or a KIT-inhibitory antibody (K44.2). On histologic evaluation, SCF injection increase d, whereas KIT inhibition decreased the number, size, and dendricity of melanocytes. Immunohistochemical expression of melanocyte differentiation antigens, including tyrosinase-related- protein-1 and gp100/pmel17, was markedly increased by treatment with SCF, and decreased by K44.2 treatment. The number of Ki67-positive melanocytes was increased in the SCF-treated tissue, suggesting a direct proliferative effect of SCF; conversely, treatment with K44.2 resulted in melanocyte loss, which did not appear reversible with prolonged treatment. These findings demonstrate that the SCF/KIT pathway remains critical in adult human skin, and that pharmacologic modulation of this single pathway can control cutaneous melanocyte homeostasis.",
keywords = "HMB-45, K44.2, Mast cell growth factor, Xenograft",
author = "Grichnik, {James M} and Burch, {James A.} and James Burchette and Shea, {Christopher R.}",
year = "1998",
month = "8",
day = "11",
doi = "10.1046/j.1523-1747.1998.00272.x",
language = "English",
volume = "111",
pages = "233--238",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis

AU - Grichnik, James M

AU - Burch, James A.

AU - Burchette, James

AU - Shea, Christopher R.

PY - 1998/8/11

Y1 - 1998/8/11

N2 - During development, the interaction of stem cell factor (SCF) with its receptor, KIT, is critical for the survival of melanocytes. Limited in vivo human studies have suggested a possible activating role of SCF on adult human melanocytes. In order to study the impact of this pathway on normal melanocyte homeostasis, human skin xenografts were treated with serial injections of recombinant human SCF or a KIT-inhibitory antibody (K44.2). On histologic evaluation, SCF injection increase d, whereas KIT inhibition decreased the number, size, and dendricity of melanocytes. Immunohistochemical expression of melanocyte differentiation antigens, including tyrosinase-related- protein-1 and gp100/pmel17, was markedly increased by treatment with SCF, and decreased by K44.2 treatment. The number of Ki67-positive melanocytes was increased in the SCF-treated tissue, suggesting a direct proliferative effect of SCF; conversely, treatment with K44.2 resulted in melanocyte loss, which did not appear reversible with prolonged treatment. These findings demonstrate that the SCF/KIT pathway remains critical in adult human skin, and that pharmacologic modulation of this single pathway can control cutaneous melanocyte homeostasis.

AB - During development, the interaction of stem cell factor (SCF) with its receptor, KIT, is critical for the survival of melanocytes. Limited in vivo human studies have suggested a possible activating role of SCF on adult human melanocytes. In order to study the impact of this pathway on normal melanocyte homeostasis, human skin xenografts were treated with serial injections of recombinant human SCF or a KIT-inhibitory antibody (K44.2). On histologic evaluation, SCF injection increase d, whereas KIT inhibition decreased the number, size, and dendricity of melanocytes. Immunohistochemical expression of melanocyte differentiation antigens, including tyrosinase-related- protein-1 and gp100/pmel17, was markedly increased by treatment with SCF, and decreased by K44.2 treatment. The number of Ki67-positive melanocytes was increased in the SCF-treated tissue, suggesting a direct proliferative effect of SCF; conversely, treatment with K44.2 resulted in melanocyte loss, which did not appear reversible with prolonged treatment. These findings demonstrate that the SCF/KIT pathway remains critical in adult human skin, and that pharmacologic modulation of this single pathway can control cutaneous melanocyte homeostasis.

KW - HMB-45

KW - K44.2

KW - Mast cell growth factor

KW - Xenograft

UR - http://www.scopus.com/inward/record.url?scp=0031927710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031927710&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1747.1998.00272.x

DO - 10.1046/j.1523-1747.1998.00272.x

M3 - Article

C2 - 9699723

AN - SCOPUS:0031927710

VL - 111

SP - 233

EP - 238

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 2

ER -